Informed prostate cancer risk-adjusted testing: a new paradigm

被引：6
作者：
Stricker, Phillip D. [1 ]
Frydenberg, Mark [2 ]
Kneebone, Andrew [3 ]
Chopra, Samarth [4 ]
机构：
[1] St Vincents Prostate Canc Ctr, Sydney, NSW, Australia
[2] Monash Univ, Dept Surg, Clayton, Vic 3800, Australia
[3] No Sydney Canc Ctr, St Leonards, NSW, Australia
[4] St Vincents Hosp, Dept Urol, Sydney, NSW 2010, Australia
来源：
BJU INTERNATIONAL | 2012年 / 110卷
关键词：
prostate cancer; PSA; screening for prostate cancer; LONG-TERM RISK; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; ANTIGEN VELOCITY; MORTALITY; MEN; DIAGNOSIS; TRENDS; AGE; BENEFIT;
D O I：
10.1111/j.1464-410X.2012.11621.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Currently there is significant confusion and polarisation about prostate cancer screening for both patients and physicians alike. We propose a risk-adjusted testing programme, which would lead to fewer patients who need to be tested and treated to save a life and also eliminate inappropriate prostate-specific antigen testing in the elderly and patients with severe co-morbidities where there is no clear benefit.
引用
收藏
页码：30 / 34
页数：5
相关论文
共 40 条
[1]   Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].
Andriole, Gerald L. ;
Grubb, Robert L., III ;
Buys, Saundra S. ;
Chia, David ;
Church, Timothy R. ;
Fouad, Mona N. ;
Gelmann, Edward P. ;
Kvale, Paul A. ;
Reding, Douglas J. ;
Weissfeld, Joel L. ;
Yokochi, Lance A. ;
Crawford, E. David ;
O'Brien, Barbara ;
Clapp, Jonathan D. ;
Rathmell, Joshua M. ;
Riley, Thomas L. ;
Hayes, Richard B. ;
Kramer, Barnett S. ;
Izmirlian, Grant ;
Miller, Anthony B. ;
Pinsky, Paul F. ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319
[2]  
Andrology Australia, PAT ASS TOOLS PSA DE
[3]  
[Anonymous], CLIN PRACT GUID ONC
[4]  
[Anonymous], SEER PROST CANC DAT
[5]   Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer [J].
Bill-Axelson, Anna ;
Holmberg, Lars ;
Ruutu, Mirja ;
Garmo, Hans ;
Stark, Jennifer R. ;
Busch, Christer ;
Nordling, Stig ;
Haggman, Michael ;
Andersson, Swen-Olof ;
Bratell, Stefan ;
Spangberg, Anders ;
Palmgren, Juni ;
Steineck, Gunnar ;
Adami, Hans-Olov ;
Johansson, Jan-Erik .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18) :1708-1717
[6]   Recent trends in prostate cancer mortality show a continuous decrease in several countries [J].
Bouchardy, Christine ;
Fioretta, Gerald ;
Rapiti, Elisabetta ;
Verkooijen, Helena Maria ;
Rapin, Charles Henry ;
Schmidlin, France ;
Miralbell, Raymond ;
Zanetti, Roberto .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) :421-429
[7]   Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability [J].
Carter, H. Ballentine ;
Ferrucci, Luigi ;
Kettermann, Anna ;
Landis, Patricia ;
Wright, E. James ;
Epstein, Jonathan I. ;
Trock, Bruce J. ;
Metter, E. Jeffrey .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (21) :1521-1527
[8]   Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial [J].
Crawford, E. David ;
Grubb, Robert, III ;
Black, Amanda ;
Andriole, Gerald L., Jr. ;
Chen, Ming-Hui ;
Izmirlian, Grant ;
Berg, Christine D. ;
D'Amico, Anthony V. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :355-361
[9]   Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment [J].
Dall'Era, Marc A. ;
Cowan, Janet E. ;
Simko, Jeffrey ;
Shinohara, Katsuto ;
Davies, Benjamin ;
Konety, Badrinath R. ;
Meng, Maxwell V. ;
Perez, Nannette ;
Greene, Kirsten ;
Carroll, Peter R. .
BJU INTERNATIONAL, 2011, 107 (08) :1232-1237
[10]   Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].
Draisma, G ;
Boer, R ;
Otto, SJ ;
van der Cruijsen, IW ;
Damhuis, RAM ;
Schröder, FH ;
de Koning, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878
1234